UNITED STATES

OMB APPROVAL

SECURITIES AND EXCHANGE
COMMISSION

OMB Number:
3235-0145

Washington, D.C. 20549

Expires: December 31, 2005

Amendment to
SCHEDULE 13G
on
SCHEDULE 13D

Estimated average burden hours per response. . 15

Item 1.

Security and Issuer

The securities in question are the common stock, $0.01 par value per share the ("Common Stock"), of Monolithic System Technology, Inc. (the “Issuer”), with a principal place of business of 1020 Stewart Drive, Sunnyvale, CA 94085.

Item 2.

Identity and Background

(a)

Name of Reporting Person:

1981 Kara Ann Berg Trust, Clyde J. Berg, Trustee.(the “Trust”).

(b)

Business Address of Reporting Person:

10050 Bandley Drive, Cupertino, CA 94014

(c)

Principal Occupation:

The Trust is organized under the laws of the State of California.

(d)

Convictions in Criminal Proceedings:

None.

(e)

Findings of guilt for violations of any federal or state securities laws:

None.

Item 3.

Source and Amount of Funds or Other Consideration

Not Applicable.

Item 4.

Purpose of Transaction

The information set forth in response to Item 6 below is incorporated by reference in response to this Item 4, in that the Stockholder Agreement described therein, to which the Trust is a party, relates to subparagraphs (a), (b), (d), (e), (g), (h) and (i) of this Item 4.  The other subparagraphs of this Item 4 are not applicable to the Trust or the Merger (as hereinafter defined) or the Stockholder Agreement described in Item 6.

Item 5.

Interest in Securities of the Issuer

(a)                                  1981 Kara Ann Berg Trust, Clyde J. Berg, Trustee, beneficially owns 2,304,830 shares of the Issuer’s Common Stock, representing 7.5% of the Issuer’s outstanding Common Stock.

(b)                                 Mr. Clyde J. Berg has the sole power to vote or direct the vote, and the sole power to dispose or direct the disposition of the 2,304,830 shares of the Issuer’s Common Stock as the

sole trustee of the Trust There is no shared power to vote or direct the vote, and no shared power to dispose of or direct the disposition of the 2,304,830 shares of the Issuer’s Common Stock.

(c)                                  Except as otherwise disclosed in this Schedule, to the best of the Trust’s knowledge, the Trust neither beneficially owns any other shares of the Issuer’s Common Stock, nor have any transactions in the Issuer’s Common Stock been effected during the past 60 days by the Trust.

(d)                                 The discussion regarding the offer by Synopsys, Inc., for up to 100% of the shares of Common Stock of the Issuer in Item 6, is incorporated by reference herein in its entirety.

(e)                                  Not Applicable.

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

On February 23, 2004, the Issuer, Synopsys, Inc., a Delaware corporation (“Synopsys”), and Mountain Acquisition Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Synopsys (“Sub”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”), whereupon through the transactions contemplated therein, Sub would commence an exchange offer to acquire up to 100% of the issued and outstanding shares of Common Stock of the Issuer at $13.50 per share (the “Offer”).  The Offer shall be made, at the election of Sub, either through (i) an all cash transaction (the “All-Cash Election”), or (ii) a combination of $6.75 in cash and a fraction of Synopsys stock having a numerator equal to $6.75 and a denominator equal to the average of the closing trading prices for one share of Synopsys’ common stock, as reported on the Nasdaq National Market, for the five trading day period ending immediately prior to the trading day immediately before the first date on which Sub accepts any shares of the Issuer’s Common Stock for exchange in the Offer.  Thereafter, Sub would merge with and into the Issuer, with the Issuer as the surviving entity (the “Merger”).

The obligation of Sub to accept for exchange or payment shares of the Issuer’s Common Stock validly tendered (and not withdrawn) is subject to general conditions pertaining to regulatory events, the absence of a court order barring the Merger and related transactions and the absence of material litigation or other events giving rise to termination of the Merger Agreement, as well as the following specific conditions: (i) that there shall be validly tendered (and not withdrawn) a number of shares of Issuer’s Common Stock that, together with any shares that Synopsys or Sub already owns, represents 50% of the sum of the aggregate number of shares of the Issuer’s Common Stock issued and outstanding immediately prior to the acceptance of shares of the Issuer’s Common Stock pursuant to the Offer, plus the aggregate number of shares of the Issuer’s Common Stock that can be issued upon the exercise of all vested options, warrants and other rights to acquire Issuer Common Stock that are outstanding immediately prior to the acceptance of shares of the Issuer’s Common Stock pursuant to the Offer (the “Minimum Condition”); (ii) that Fu-Chieh Hsu and Wing-Yu Leung continue to be employed by the Issuer; (iii) that no more than 25% of the engineers employed by the Issuer or its subsidiaries who have received offers of at-will employment from Synopsys, on terms no less favorable than the terms of their employment with the Issuer or its subsidiaries on the date of the Merger Agreement,

shall cease to be employed by the Issuer or any of its subsidiaries;  (iv) there is no legal proceeding threatened or pending to which a governmental body is or is threatened to become a party challenging or seeking to restrain or prohibit the acquisition of or delivery of consideration in exchange for shares of Common Stock or seeking to prohibit or limit Synopsys’ ownership rights with respect to the Common Stock acquired through the Offer; (v) the shares of Synopsys common stock to be issued in the Merger (if the All-Cash Election is not made) have been approved for listing on the Nasdaq National Market; and (vi)  Fu-Chieh Hsu and Wing-Yu Leung have executed and delivered Noncompetition Agreements to Synopsys.

The Offer shall initially be scheduled to expire 20 business days following the commencement of the Offer (the “Term”).  At the election of Sub or the Issuer, prior to such expiration, if the Minimum Condition is not met, the Term may be extended for additional periods of 20 business days, but in no case are such extensions to continue beyond July 31, 2004.

If Sub acquires at least a majority of the outstanding Issuer Common Stock pursuant to the Offer, the Merger Agreement provides that Synopsys will be entitled to designate a number of directors to the Issuer’s board (the “Board”) sufficient to give Synopsys a proportionate representation on the Board (“Synopsys' Proportionate Representation”) equal to that number of directors (rounded up to the next whole number) that equals the product of the total number of directors on the Board multiplied by the percentage that the aggregate number of shares of the Issuer’s Common Stock beneficially owned by Synopsys or Sub bears to the total number of shares of the Issuer’s Common Stock issued and outstanding.  Upon request by Sub, the Issuer will increase the size of the Board or secure the resignations of the number of directors necessary to provide Synopsys with Synopsys' Proportionate Representation and will cause Synopsys’ designees to be so elected or appointed; provided, however, that until the Merger, the Board will have at least two directors who were directors of the Issuer as of the signing of the Merger Agreement (or failing the availability of one or both of such directors, a designee of the other such director or the Board).

The Merger Agreement prohibits the Issuer from declaring, setting aside for payment or paying any dividend, or making any other distribution in respect of any shares of its Common Stock or otherwise making any payments to its stockholders in their capacity as such.

If adoption of the Merger by a vote of the Issuer’s stockholders is required by applicable law, under the terms of the Merger Agreement, the Issuer will take all necessary actions to comply with such applicable law.

If the requirements of the Offer are fulfilled, including the Minimum Condition, and if Synopsys so elects, then:

•                  Upon consummation of the Merger, the Issuer’s Common Stock will cease to be quoted on any quotation system or exchange.

•                  Upon consummation of the Merger, the Issuer’s Common Stock will become eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act.

Concurrently with the execution of the Merger Agreement, the Trust entered into a Stockholder Agreement pursuant to which it agreed to tender (and agreed not to withdraw) its shares into the Offer.  The Stockholder Agreement also provides that prior to the tender of its shares of Common Stock pursuant to the Offer, the Trust is obligated to vote the Issuer’s Common Stock beneficially owned by it (i) in favor of the Merger, the adoption of the Merger Agreement and the approval of the terms thereof and the transactions contemplated therein; (ii) against any action or agreement that would result in a breach in any material respect of any covenant or any other obligation or agreement of the Issuer under the Merger Agreement or in a breach in any material respect of any representation or warranty of the Issuer in the Merger Agreement; (iii) against any amendment of the Issuer’s articles of incorporation and by-laws or any other action or agreement that is intended or could reasonably be expected to impede, interfere with, delay, postpone or discourage the Offer or the Merger or change in any manner the voting rights of any class of the Issuer’s Common Stock.  Pursuant to the Stockholder Agreement, the Trust has granted an irrevocable proxy to Synopsys to vote its shares of the Issuer’s Common Stock on the matters listed above, which will expire on the earlier of (i) the date upon which the Merger Agreement is terminated in accordance with its provisions, or (ii) the date upon which the Merger becomes effective.  The Trust retains the power to vote the Issuer’s Common Stock on all other matters.

The Stockholder Agreement automatically terminates upon consummation of the Merger, upon any amendment to the Merger Agreement without the Trust's consent that decreases the per share merger consideration or upon termination of the Merger Agreement in accordance with its terms.  The  Merger Agreement may be terminated (a) by mutual consent of Synopsys and the Issuer; (b) by either Synopsys or the Issuer if a court or governmental body issues an order permanently enjoining or making illegal the Merger; (c) by either Synopsys or the Issuer if the Offer expires without Synopsys having accepted any shares of the Issuer’s Common Stock or if the Offer shall not have been accepted by July 31, 2004; (d) by Synopsys if the Issuer's Board retracts its recommendation of the Synopsys transaction; (e) by the Issuer to accept an unsolicited, bona fide written offer by a third party to purchase all of the outstanding shares of the Issuer's Common Stock, after the Board determines, consistent with its obligations under the Merger Agreement and its fiduciary duties, that such third party offer is more favorable to the stockholders of the Issuer than the Offer, after providing Synopsys with an opportunity to amend the Offer or enter into an alternative transaction with the Issuer and then after paying a termination fee to Synopsys of $10 million; (f) by Synopsys if the Issuer’s representations and warranties are materially inaccurate, such that there has been a material adverse effect on the Issuer, or any of the Issuer’s covenants shall have been materially breached, after the Issuer has had an opportunity to cure such breach or inaccuracy, and after paying the Issuer a termination fee of $10 million; (g) by the Issuer if any of Synopsys’ representations and warranties are materially inaccurate or if its covenants are materially breached, which causes a material adverse effect on Synopsys’ ability to consummate the Merger, and after Synopsys has had an opportunity to cure such breach or inaccuracy; or (h) by Synopsys if a material adverse effect shall have occurred or is reasonably likely to occur with respect to the Issuer, and after paying the Issuer a termination fee of $10 million

During the term of the Stockholder Agreement, the Trust has agreed, except as otherwise contemplated by the Stockholder Agreement, not to grant any proxies relating to, or sell, transfer, give, pledge, encumber, assign or otherwise dispose of any shares of the Issuer’s Common Stock.  Any additional shares of the Issuer’s Common Stock acquired by the Trust during the term of the Merger Agreement will be subject to the Stockholder Agreement.

Item 7.

Material to Be Filed as Exhibits

Exhibit

Exhibit Description

(1)

Agreement and Plan of Merger and Reorganization, dated February 23,  2004, among Synopsys, Inc., Mountain Acquisition Sub, Inc., a wholly-owned subsidiary of Synopsys, Inc., and Monolithic System Technology, Inc., is incorporated by reference in its entirety from exhibit 2.1 to Synopsys, Inc.’s Current Report on Form 8-K (Commission File No. 000-19807) filed with the Securities and Exchange Commission on February 26, 2004.

(2)

Form of Stockholder Agreement, dated February 23, 2004, among Synopsys, Inc., Mountain Acquisition Sub, Inc., a wholly-owned subsidiary of Synopsys, Inc., and the stockholder of Monolithic System Technology, Inc., identified on the signature page, is incorporated by reference in its entirety from exhibit 2.2 to Synopsys, Inc.’s Current Report on Form 8-K (Commission File No. 000-19807) filed with the Securities and Exchange Commission on February 26, 2004.

Dated:  March 4, 2004

1981 Kara Ann Berg Trust

By:

/s/ Clyde J. Berg

Its:

Trustee